Fig. 7: Schematic diagram of lenvatinib inhibition of EMT in ICC cells.
Lenvatinib enhanced AZGP1 activity through H3K27Ac modification and inhibited the downstream TGF-β1/Smad3 signaling pathway.
Fig. 7: Schematic diagram of lenvatinib inhibition of EMT in ICC cells. | Cell Death & Disease
